1. Home
  2. KPTI vs YTRA Comparison

KPTI vs YTRA Comparison

Compare KPTI & YTRA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • KPTI
  • YTRA
  • Stock Information
  • Founded
  • KPTI 2008
  • YTRA 2005
  • Country
  • KPTI United States
  • YTRA India
  • Employees
  • KPTI N/A
  • YTRA N/A
  • Industry
  • KPTI Biotechnology: Pharmaceutical Preparations
  • YTRA Transportation Services
  • Sector
  • KPTI Health Care
  • YTRA Consumer Discretionary
  • Exchange
  • KPTI Nasdaq
  • YTRA Nasdaq
  • Market Cap
  • KPTI 44.5M
  • YTRA 43.3M
  • IPO Year
  • KPTI 2013
  • YTRA N/A
  • Fundamental
  • Price
  • KPTI $4.20
  • YTRA $0.96
  • Analyst Decision
  • KPTI Buy
  • YTRA Strong Buy
  • Analyst Count
  • KPTI 6
  • YTRA 1
  • Target Price
  • KPTI $48.50
  • YTRA $3.00
  • AVG Volume (30 Days)
  • KPTI 86.5K
  • YTRA 107.0K
  • Earning Date
  • KPTI 05-12-2025
  • YTRA 05-29-2025
  • Dividend Yield
  • KPTI N/A
  • YTRA N/A
  • EPS Growth
  • KPTI N/A
  • YTRA N/A
  • EPS
  • KPTI N/A
  • YTRA N/A
  • Revenue
  • KPTI $142,126,000.00
  • YTRA $93,125,316.00
  • Revenue This Year
  • KPTI $2.34
  • YTRA N/A
  • Revenue Next Year
  • KPTI $13.81
  • YTRA N/A
  • P/E Ratio
  • KPTI N/A
  • YTRA N/A
  • Revenue Growth
  • KPTI 1.19
  • YTRA 89.92
  • 52 Week Low
  • KPTI $3.51
  • YTRA $0.58
  • 52 Week High
  • KPTI $17.40
  • YTRA $1.75
  • Technical
  • Relative Strength Index (RSI)
  • KPTI 35.16
  • YTRA 70.02
  • Support Level
  • KPTI $4.33
  • YTRA $0.79
  • Resistance Level
  • KPTI $4.65
  • YTRA $0.85
  • Average True Range (ATR)
  • KPTI 0.47
  • YTRA 0.06
  • MACD
  • KPTI -0.12
  • YTRA 0.02
  • Stochastic Oscillator
  • KPTI 8.95
  • YTRA 85.79

About KPTI Karyopharm Therapeutics Inc.

Karyopharm Therapeutics Inc is a commercial-stage pharmaceutical company pioneering novel cancer therapies and dedicated to the discovery, development, and commercialization of drugs directed against nuclear export for the treatment of cancer and other diseases. XPOVIO (selinexor), is approved in the U.S. in multiple hematologic malignancy indications, including in combination with Velcade (bortezomib) and dexamethasone for the treatment of adult patients with multiple myeloma after at least one prior therapy, in combination with dexamethasone for the treatment of adult patients with heavily pretreated multiple myeloma and as a monotherapy for the treatment of adult patients with relapsed or refractory diffuse large B-cell lymphoma. The company derives its revenue from United States.

About YTRA Yatra Online Inc.

Yatra Online Inc is an Indian consumer travel platform provider and online travel agent. The company is organized into the following business segments; Air Ticketing which derives maximum revenue, Hotels and Packages, and Other Services. It mainly provides travel-related services, which include domestic and international air ticketing, hotel bookings, homestays, holiday packages, bus ticketing, rail ticketing, activities and ancillary services. It also involves hosting advertisements on its internet websites, the sale of rail and bus tickets, and facilitating website access to travel insurance companies. Some of its applications include Yatra Mini, Yatra Web Check-In, Yatra Corporate, and Travelguru HomeStay.

Share on Social Networks: